| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8949223 | Journal of Geriatric Oncology | 2018 | 6 Pages |
Abstract
A tailored regimen of BCG administration is possible and safe in frail elderly patients, limiting side effects and risk of undertreatment but maintaining oncological outcomes. Preliminary results in a small patients group are promising but larger randomized studies are needed to confirm our data.
Keywords
IADLUTUCCSMEORTCCTCAEP valueGFRCockcroft–GaultUICCNCCNNMIBCCGABCGCISASACumulative Illness Rating Scale for GeriatricsTURMIBCUpper urinary tract cancerSIOGADLEAUEuropean Association of UrologyAmerican Society of AnesthesiologySafetycomputed tomographyElderlyBladder cancerMuscle invasive bladder cancerbody mass indexBMINational Comprehensive Cancer NetworkComplicationsInstrumental Activities of Daily LivingActivities of daily livingCancer-specific mortalityGlomerular filtration rateTarget therapyUpper tract urothelial carcinomaCarcinoma in situ
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Marco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, Giuseppe Palermo, Emilio Sacco, PierFrancesco Bassi,